SCHEMBL21067688

SCHEMBL21067688

NCCCSC[C@H](N)CO

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11513997 0.88 NOS2 (0.32)
SCHEMBL11516800 0.86 BHMT (0.33)
SCHEMBL11514786 0.86 BHMT (0.33)
SCHEMBL11512414 0.86 BHMT (0.33)
SCHEMBL10701088 0.77 CES2 (0.42) CYP1A2
SCHEMBL11514921 0.72
Phosphoric Acid SCHEMBL11089034 0.70 S1PR2 (0.44)
SCHEMBL4593613 0.70
SCHEMBL4017239 0.70 ARG1 (0.58)
SCHEMBL4017246 0.70 ARG1 (0.58)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11446398-B2 Regulated biocircuit systems OBSIDIAN THERAPEUTICS, INC. (US) 2022-09-20 US disclosed
US-20190192691-A1 REGULATED BIOCIRCUIT SYSTEMS OBSIDIAN THERAPEUTICS, INC. 2019-06-27 US disclosed